Metraipolis › archive › dc_bd2a8134fbe5

Immune checkpoint inhibitor-induced bullous pemphigoid: a systematic review of clinical characteristics and outcomes based on case reports — Europe PMC PMID:41859123

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41859123
DOI
10.3389/fimmu.2026.1745011
License (as archived)
solo-consultazione
Archived
2026-11-05T03:44:57.813Z
SHA-256 of the archived text
53a16c27489376cdd3917efe82d279d075f4a57abdcc5d720c4f6d11f9038776
Stable URL of this page
https://metraipolis.com/documento/dc_bd2a8134fbe5

How to cite

Immune checkpoint inhibitor-induced bullous pemphigoid: a systematic review of clinical characteristics and outcomes based on case reports — Europe PMC PMID:41859123 — Europe PMC (en), https://europepmc.org/article/MED/41859123 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bd2a8134fbe5 (Metraipolis archive dc_bd2a8134fbe5, sha256 53a16c27489376cdd3917efe82d279d075f4a57abdcc5d720c4f6d11f9038776)
BibTeX
@misc{dcbd2a8134fbe5,
  title = {Immune checkpoint inhibitor-induced bullous pemphigoid: a systematic review of clinical characteristics and outcomes based on case reports — Europe PMC PMID:41859123},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41859123},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bd2a8134fbe5; sha256 53a16c27489376cdd3917efe82d279d075f4a57abdcc5d720c4f6d11f9038776},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41859123. Agents can read the archived copy with the MCP tool read_document.